TE_11341
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR12F |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | ENSG00000248605, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 181.46 |
| Counts of samples | TCGA_tumor:160; TCGA_normal:0; GTEx:0 |
| TSS | chr5(-):25569125 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_11341.1 | - | Intergenic | Non-coding | Non-coding | chr5(-):25513020,25513040,25519479,25519576,25568997,25569126 |
| teRNA_11341.2 | - | Intergenic | Non-coding | Non-coding | chr5(-):25452946,25452966,25517884,25517968,25519479,25519576,25568997,25569126 |
| teRNA_11341.3 | - | Intergenic | Non-coding | Non-coding | chr5(-):25513020,25513040,25517884,25517968,25519479,25519576,25568997,25569126 |
| teRNA_11341.4 | - | Intergenic | Non-coding | Non-coding | chr5(-):25517039,25517059,25517884,25517968,25519479,25519576,25568997,25569126 |
| teRNA_11341.5 | - | Intergenic | Non-coding | Non-coding | chr5(-):25517209,25517229,25517884,25517968,25519479,25519576,25568997,25569126 |
| teRNA_11341.6 | ENSG00000248605 | Chimeric | Non-coding | Non-coding | chr5(-):25405073,25405093,25413767,25413844,25452804,25452966,25519479,25519576,25568997,25569126 |
| teRNA_11341.7 | ENSG00000248605 | Chimeric | Non-coding | Non-coding | chr5(-):25413824,25413844,25452804,25452966,25519479,25519576,25568997,25569126 |
| teRNA_11341.8 | - | Intergenic | Non-coding | Non-coding | chr5(-):25434191,25434211,25435242,25435273,25452804,25452966,25519479,25519576,25568997,25569126 |
| teRNA_11341.9 | - | Intergenic | Non-coding | Non-coding | chr5(-):25434191,25434211,25452804,25452966,25519479,25519576,25568997,25569126 |
| teRNA_11341.10 | - | Intergenic | Non-coding | Non-coding | chr5(-):25452946,25452966,25471298,25471401,25519479,25519576,25568997,25569126 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
